1. Home
  2. SBFM vs PPBT Comparison

SBFM vs PPBT Comparison

Compare SBFM & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunshine Biopharma Inc.

SBFM

Sunshine Biopharma Inc.

HOLD

Current Price

$1.17

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$0.58

Market Cap

6.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBFM
PPBT
Founded
2006
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.0M
6.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SBFM
PPBT
Price
$1.17
$0.58
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
36.6K
102.9K
Earning Date
03-31-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$37,323,742.00
N/A
Revenue This Year
$10.26
N/A
Revenue Next Year
$32.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.24
N/A
52 Week Low
$1.15
$0.53
52 Week High
$3.90
$3.48

Technical Indicators

Market Signals
Indicator
SBFM
PPBT
Relative Strength Index (RSI) 37.93 36.88
Support Level $1.15 $0.56
Resistance Level $1.23 $0.63
Average True Range (ATR) 0.06 0.04
MACD 0.00 0.00
Stochastic Oscillator 10.00 32.43

Price Performance

Historical Comparison
SBFM
PPBT

About SBFM Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

Share on Social Networks: